HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor (Q34604211)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor
scientific article

    Statements

    title
    HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    17237277
    retrieved
    3 August 2017
    main subject
    cannabinoids
    0 references
    author name string
    Michael Schlesinger
    series ordinal
    2
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    17237277
    retrieved
    3 August 2017
    Esther Priel
    series ordinal
    3
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    17237277
    retrieved
    3 August 2017
    Ruth Rabinowitz
    series ordinal
    4
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    17237277
    retrieved
    3 August 2017
    Eduard Berenshtein
    series ordinal
    5
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    17237277
    retrieved
    3 August 2017
    Mordechai Chevion
    series ordinal
    6
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    17237277
    retrieved
    3 August 2017
    publication date
    1 January 2007
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    17237277
    retrieved
    3 August 2017

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q34604211&oldid=1578084196"